The AstraZeneca-Oxford vaccine was shown to be 79 per cent effective in preventing symptomatic illness. — Reuters picLONDON, March 23 — AstraZeneca will provide Europe’s drug regulator with data from a US trial of its Covid-19 vaccine and the watchdog could adjust its assessment of the shot if needed, the head of the European Medicines Agency said today.
Cooke, however, did not deliberate much on doubts expressed by US federal health officials that AstraZeneca may have used “outdated information” in the data released yesterday. The AstraZeneca-Oxford vaccine was shown to be 79 per cent effective in preventing symptomatic illness and did not increase risk of blood clots, according to interim data from the late-stage trials in Chile, Peru and United States.
Source: Law Daily Report (lawdailyreport.net)